XELSTRYM™ (dextroamphetamine) transdermal system, CII, to be revealed as available soon at the 2023 American Professional Society of ADHD and Related Disorders (APSARD) Conference

/PRNewswire/ -- Noven Pharmaceuticals. Inc., (Noven), a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. focusing on the development of...

Related Keywords

Miami ,Florida ,United States ,Jersey ,Orlando ,American ,Naruhito Higo ,Greg Mattingly ,Natalie Andrade ,Noven Pharmaceuticals ,Hisamitsu Pharmaceutical Co Inc ,Affairs Team ,Washington University ,National Pregnancy Registry For Psychiatric Medications ,Prnewswire Noven Pharmaceuticals ,American Professional Society ,Noven Pharmaceuticals Inc ,Hyperactivity Disorder ,Related Disorders ,Platinum Sponsor ,Associate Clinical Professor ,President Elect ,Chief Executive Officer ,Medical Affairs Team ,Trainee Award ,Medication Guide ,Medication Guideand Full Prescribing Information ,Adverse Reactions ,National Pregnancy Registry ,Psychiatric Medications ,Nc ,